Category: Drug Discovery
Drug Discovery market research reports by DelveInsight
-
Huntington’s Disease - Pipeline Insight, 2025
DelveInsight’s, “Huntington’s Disease - Pipeline Insight, 2025” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Huntington’s Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the t ... Read More
-
Sarcopenia - Pipeline Insight, 2025
DelveInsight’s, “Sarcopenia - Pipeline Insight, 2025” report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in Sarcopenia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessmen ... Read More
-
Hypertriglyceridemia - Pipeline Insight, 2025
DelveInsight’s, “Hypertriglyceridemia - Pipeline Insight, 2025” report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in Hypertriglyceridemia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the th ... Read More
-
Chronic Spinal Cord Injury- Pipeline Insight, 2025
DelveInsight’s, “Chronic Spinal Cord Injury- Pipeline Insight, 2025” report provides comprehensive insights about 4+ companies and 5+ pipeline drugs in Chronic Spinal Cord Injury pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also cove ... Read More
-
Allergic Rhinitis - Market Insight, Epidemiology, and Market Forecast - 2034
Key Highlights In 2023, the Allergic Rhinitis Market Size was highest in the US among the 7MM, accounting for approximately USD 3,600 million which is further expected to increase by 2034. In 2023, the prevalence of Allergic rhinitis was highest in Japan among the 7MM, accounting for approximately 6 ... Read More
-
WHIM Syndrome - Market Insight, Epidemiology, and Market Forecast - 2034
Key Highlights WHIM syndrome is a rare genetic disorder caused by CXCR4 mutations, leading to immunodeficiency, warts, hypogammaglobulinemia, and myelokathexis. In 2023, the diagnosed prevalent population in the 7MM was estimated to be around 179 individuals. WHIM is a significant health issue in th ... Read More
-
Post-Bariatric Hypoglycemia - Market Insight, Epidemiology, and Market Forecast - 2034
Key Highlights In 2023, the United States accounted for approximately 90% of the total Post-Bariatric hypoglycemia market size within the seven major markets. Post-Bariatric hypoglycemia is the development of hypoglycemia (low blood sugar) following bariatric surgery, such as gastric bypass or sleev ... Read More
-
1,3-Beta-Glucan Synthase Inhibitor - Pipeline Insight, 2025
“1,3-Beta-Glucan Synthase Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 1,3-Beta-Glucan Synthase Inhibitor development. The report provides detailed coverage of the pipeli ... Read More
-
5-HT4 Agonist - Pipeline Insight, 2025
“5-HT4 Agonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT4 Agonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, ... Read More
-
Adenosine A1 Receptor Agonist - Pipeline Insight, 2025
“Adenosine A1 Receptor Agonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Adenosine A1 Receptor Agonist development. The report provides detailed coverage of the pipeline landsca ... Read More
-
Adenosine A3 Receptor Antagonist - Pipeline Insight, 2025
“Adenosine A3 Receptor Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Adenosine A3 Receptor Antagonist development. The report provides detailed coverage of the pipeline l ... Read More
-
Adenosine A2A Receptor Antagonist - Pipeline Insight, 2025
“Adenosine A2A Receptor Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Adenosine A2A Receptor Antagonist development. The report provides detailed coverage of the pipeline ... Read More
-
Alpha Receptor Antagonist - Pipeline Insight, 2025
“Alpha Receptor Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Alpha Receptor Antagonist development. The report provides detailed coverage of the pipeline landscape for t ... Read More
-
Alpha-2 Antagonist - Pipeline Insight, 2025
“Alpha-2 Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Alpha-2 Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanism ... Read More
-
Amyloid Protein Blockers - Pipeline Insight, 2025
“Amyloid Protein Blockers - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Amyloid Protein Blockers development. The report provides detailed coverage of the pipeline landscape for thi ... Read More
-
Angiopoietin Inhibitor - Pipeline Insight, 2025
“Angiopoietin Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Angiopoietin Inhibitor development. The report provides detailed coverage of the pipeline landscape for this me ... Read More
-
Factor IX - Pipeline Insight, 2025
DelveInsight’s, “Factor IX - Pipeline Insight, 2025” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Factor IX pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by ... Read More
-
Interleukin-13 (IL-13) Inhibitor - Pipeline Insight, 2025
“Interleukin-13 (IL-13) Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Interleukin-13 (IL-13) Inhibitor development. The report provides detailed coverage of the pipeline l ... Read More
-
Interleukin-12 (IL-12) Inhibitor - Pipeline Insight, 2025
“Interleukin-12 (IL-12) Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Interleukin-12 (IL-12) Inhibitor development. The report provides detailed coverage of the pipeline l ... Read More
-
Potassium Channel Openers - Pipeline Insight, 2025
“Potassium Channel Openers - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Potassium Channel Openers development. The report provides detailed coverage of the pipeline landscape for t ... Read More
-
Serotonin Transporter Inhibitor - Pipeline Insight, 2025
“Serotonin Transporter Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Serotonin Transporter Inhibitor development. The report provides detailed coverage of the pipeline lan ... Read More
-
TGF-Beta Inhibitor - Pipeline Insight, 2025
“TGF-Beta Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across TGF-Beta Inhibitor development. The report provides detailed coverage of the pipeline landscape for this mechanism ... Read More
-
Transient Receptor Potential Cation Channel, Subfamily A, Member 1 (TRPA1) Antagonist - Pipeline Insight, 2025
“Transient Receptor Potential Cation Channel, Subfamily A, Member 1 (TRPA1) Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Transient Receptor Potential Cation Channel, Sub ... Read More
-
Ocular Hypertension - Pipeline Insight, 2025
DelveInsight’s, “Ocular Hypertension - Pipeline Insight, 2025” report provides comprehensive insights about 50+ companies and 75+ pipeline drugs in Ocular Hypertension pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the ther ... Read More
-
Neuroendocrine tumors - Pipeline Insight, 2025
DelveInsight’s, “Neuroendocrine tumors - Pipeline Insight, 2025” report provides comprehensive insights about 100+ companies and 120+ pipeline drugs in Neuroendocrine tumors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers th ... Read More
Research Assistance
